(Q73635266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

10

Sawyer WH

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Ala Y

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Morin D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Mahé E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Cotte N

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Mouillac B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jard S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Barberis C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Tribollet E

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Dreifuss JJ

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Wo NC

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Chan WY

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kolodziejczyk AS

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Cheng LL

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Manning M

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

285-293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Molecular cloning of the receptor for human antidiuretic hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: Relation to adenylate cyclase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

[125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Structure and expression of a human oxytocin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

A new tritiated oxytocin receptor radioligand--synthesis and application for localization of central oxytocin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

SOLID-PHASE PEPTIDE SYNTHESIS. 3. AN IMPROVED SYNTHESIS OF BRADYKININ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Synthesis and characterization of iodinated vasopressin antagonists which retain high affinity for the vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

A highly sensitive adenylate cyclase assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Differences in the antidiuretic responses of rats to the intravenous administration of lysine and arginine vasopressins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

Autoradiographic localization of vasopressin and oxytocin binding sites in rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

3HdesGly-NH29-d(CH2)5D-Ileu2,Ileu4AVP: An AVP V2 receptor antagonist radioligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901021-2

10.1016/S0014-2999(97)01021-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274991%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference